The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.

NEW YORK – Irish diagnostic firm Trinity Biotech announced on Wednesday that it has entered into a $25 million standby equity purchase agreement with an affiliate of its financing partner Yorkville ...

The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.

The interferon-gamma release assay for latent tuberculosis infection is designed for use on Diasorin's automated, high-throughput Liaison XL platform.

Last week, readers were most interested in a story about a deal between QuidelOrtho and Shenzhen Lifotronic Technology covering immunoassays.

Labcorp said it will be using the company's FDA-cleared AISight Dx platform across its national network of anatomic pathology labs and hospital collaborations.

The transition from testing the dead to testing the living is the latest example of how genomics is expanding horizons for ...

The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and ...

The cleared assays included point-of-care and home tests for infectious and chronic diseases and drugs of abuse.

The agreement pertains to multiple immunoassay analyzers and test menus that QuidelOrtho expects will increase its competitiveness in international tenders.

The test runs on the company's OneBreath platform and is designed to assess a patient's risk for postoperative pneumonia.